Stock Events

Stock Events

Paion 

$0.010000
17
+$0.00+0% Thursday 20:00

Statistics

Day High
0.05
Day Low
0.05
52W High
0.05
52W Low
0.0001
Volume
30,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

22AugExpected
Q4 2019
Q1 2020
Q2 2020
Q3 2020
Q3 2020
Q1 2021
Q2 2021
-0.11
-0.07
-0.04
0
Expected EPS
0
Actual EPS
-0.1045

Financials

-2.1%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
70.71MRevenue
-1.48MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PAIOF. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap143.68B
Pfizer is a global pharmaceutical company that competes with Paion in the development of drugs across various therapeutic areas, including anesthesia where Paion has a focus.
Johnson & Johnson
JNJ
Mkt Cap549.78B
Johnson & Johnson, through its pharmaceutical segment, competes in developing medications that can overlap with Paion's portfolio, including anesthesia and critical care.
Merck
MRK
Mkt Cap281.24B
Merck & Co., Inc. is involved in the discovery, development, and marketing of drugs in areas that can compete with Paion's interests, particularly in anesthesia and pain management.
Abbvie
ABBV
Mkt Cap382.49B
AbbVie competes with Paion in the pharmaceutical sector, focusing on areas including anesthesia and pain management, where Paion also operates.
Novartis
NVS
Mkt Cap280.64B
Novartis AG is a global healthcare company that has a broad portfolio, including drugs in the anesthesia area, making it a competitor to Paion.
Bristol-Myers Squibb
BMY
Mkt Cap110.27B
Bristol-Myers Squibb Company is involved in the discovery and development of drugs in several therapeutic areas that could compete with Paion's focus areas.
Astrazeneca
AZN
Mkt Cap271.29B
AstraZeneca operates in various therapeutic segments, including areas that overlap with Paion's drug development efforts, making it a competitor.
Sanofi
SNY
Mkt Cap101.45B
Sanofi is a global pharmaceutical company with a wide range of products that could compete with Paion, especially in the development of anesthesia-related treatments.
GSK
GSK
Mkt Cap101.54B
GlaxoSmithKline plc is involved in the creation and marketing of pharmaceutical products, including those in areas that compete with Paion's focus.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap36.66B
Teva Pharmaceutical Industries Ltd. is a global company that manufactures generic and specialty medicines, including those in the field of anesthesia, competing with Paion.

About

Paion AG is a specialized biopharmaceutical company that operates globally, focusing on the development and commercialization of medications intended for hospital settings, specifically for sedation, anesthesia, and critical care management. Its primary product in development is Remimazolam, an ultra-short-acting intravenous benzodiazepine-class drug serving as both a sedative and an anesthetic, which is currently undergoing clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline further includes Angiotensin II, a vasoconstrictor designed for adults experiencing refractory low blood pressure due to septic or other forms of distributive shock, and Eravacycline, a novel fluorocycline antibiotic aimed at treating complicated intra-abdominal infections in adults. Paion AG maintains strategic partnerships and licensing arrangements with several entities, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. The company was founded in the year 2000 and has its headquarters in Aachen, Germany.
Show more...
CEO
Mr. Gregor Siebert
Employees
64
Country
Germany
ISIN
DE000A3E5EG5

Listings

LSE
GB
0NF3.LSE
STU
DE
PA8.STU
OTC Link
US
PAIOF
MU
DE
PA8.MU

0 Comments

Share your thoughts

FAQ

What is Paion stock price today?▼
The current price of PAIOF is $0.01 USD — it has increased by +0% in the past 24 hours. Watch Paion stock price performance more closely on the chart.
What is Paion stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Paion stocks are traded under the ticker PAIOF.
Is Paion stock price growing?▼
PAIOF stock has fallen by -0% compared to the previous week, the month change is a +0% rise, over the last year Paion has showed a +0% increase.
What were Paion earnings last quarter?▼
PAIOF earnings for the last quarter are -0.1 USD per share, whereas the estimation was 0 USD resulting in a -∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Paion revenue for the last year?▼
Paion revenue for the last year amounts to 70.71M USD.
What is Paion net income for the last year?▼
PAIOF net income for the last year is -1.48M USD.
How many employees does Paion have?▼
As of June 27, 2026, the company has 64 employees.
In which sector is Paion located?▼
Paion operates in the Health & Wellness sector.
When did Paion complete a stock split?▼
The last stock split for Paion was on April 12, 2023 with a ratio of 1:10.
Where is Paion headquartered?▼
Paion is headquartered in Aachen, Germany.